Two pharmacodynamic models for assessing the efficacy of amoxicillin- clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 1, 1999, Pages 29-34

  Woodnutt, Gary ^a   Berry, Valerie ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0032952390     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.1.29     Document Type: Article

References (18)

1. Andes, D., A. Urban, and W. A. Craig. 1995. In-vivo activity of amoxicillin and amoxicillin-clavulanate against penicillin-resistant pneumococci, abstr. A82, p. 16. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Applebaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
3. Caputo, G. M., P. C. Applebaum, and H. H. Liu. 1993. Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features. Arch. Intern. Med. 153:1301-1310.
4. Celin, S. E., C. D. Bluestone, J. Stephenson, H. M. Yilmaz, and J. J. Collins. 1991. Bacteriology of acute otitis media in adults. JAMA 266:2249-2252.
5. Craig, W. A. 1993. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens. Eur. J. Clin. Microbiol. Infect. Dis. 12(Suppl. 1):6-8.
6. Craig, W. A., and D. Andes. 1996. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect. Dis. J. 15:255-259.
7. Craig, W. A., and S. Ebert. 1991. Killing and regrowth of bacteria in vitro: a review. Scand. J. Infect. Dis. 74:S63-S70.
8. Del Beccaro, M. A., P. M. Mendelman, A. F. Inglis, M. A. Richardson, N. O. Duncan, C. R. Clausen, and T. L. Stull. 1992. Bacteriology of acute otitis media: a new perspective. J. Pediatr. 120:81-84.
9. Drusano, G. L., 1988. Role of pharmacokinetics in outcome of infections. Antimicrob. Agents Chemother. 32:289-297.
10. Gold, H. S., and R. C. Moellering. 1996. Antimicrobial-drug resistance. N. Engl. J. Med. 335:1445-1453.
11. Gruneberg, R. N. 1996. The Alexander Project: using in-vitro susceptibility data for choosing empirical therapy in LRTI. J. Antimicrob. Chemother. 38 (Suppl. A):155-170.
12. Gwaltney, J. M. 1996. Acute community acquired sinusitis. Clin. Infect. Dis. 23:1209-1223.
13. Jackson, D., D. L. Cooper, R. Horton, P. F. Langley, D. S. Staniforth, and A. J. Sutton. 1982. Absorption, pharmacokinetic and metabolic studies with Augmentin. In E. A. P. Croydon and M. F. Michael (ed.). Augmentin: clavulanate potentiated amoxycillin. Proceedings of the European Symposium, Scheveningen, The Netherlands. Excerpta Medica, Amsterdam, The Netherlands.
14. Jacobs, M. R., S. Bajaksouzian, D. Burch, J. Poupard, and P. C. Appelbaum. 1995. Activity of amoxicillin ± clavulanate against Streptococcus pneumoniae strains from patients with acute otitis media in eastern Europe, Israel and USA, abstr. E29, p. 90. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Smith, G. M., and K. H. Abbott. 1994. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or β-lactamase-producing Haemophilus influenzae. Antimicrob. Agents Chemother. 38:608-610.
17. Soriano, F., C. Ponte, E. Nieto, and A. Parra. 1996. Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumoniae. J. Antimicrob. Chemother. 38:227-236.
18. Vogelman, B., S. Gundmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847.